Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder

Neuroscience Letters

Volumn 415, Issue 1, 2007, Pages 87-89

  Walz, Julio C ^a   Andreazza, Ana C ^a,b   Frey, Benício N ^a,b   Cacilhas, Alice A ^a   Ceresér, Keila M M ^a   Cunha, Angelo B M ^c   Weyne, Fernanda ^a   Stertz, Laura ^a   Santin, Aida ^a   Gonçalves, Carlos A ^b   Kapczinski, Flávio ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Bipolar disorder; Depression; Mania; Neurotrophin 3; Pathophysiology

Indexed keywords

NEUROTROPHIN 3;

ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD LEVEL; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MANIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN; BRAIN CHEMISTRY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROTROPHIN 3; PREDICTIVE VALUE OF TESTS; UP-REGULATION;

EID: 33847628372     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.01.002     Document Type: Article

References (21)

1. Agerman K., and Ernfors P. Differential influence of BDNF and NT3 on the expression of calcium binding proteins and neuropeptide Y in vivo. Neuroreport 14 (2003) 2183-2187
2. Belmaker R.H. Bipolar disorder. N. Engl. J. Med. 351 (2004) 476-486
3. Cunha A.B., Frey B.N., Andreazza A.C., Godói J.D., Rosa A.R., Gonçalves C.A., Santin A., and Kapczinski F. Serum brain-derived neurotrophic is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett. 398 (2006) 215-219
4. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview for DSM-IV (SCID-I) (1998), Biomedics Research Department, New York
5. Giehl K.M., Röhrig S., Bonatz H., Gutjahr M., Leiner B., Bartke I., Yan Q., Reichardt L.F., Backus C., Welcher A.A., Dethleffsen K., Mestres P., and Meyer M. Endogenous brain-derived neurotrophic factor and neurotrophin-3 antagonistically regulate survival of axotomized corticospinal neurons in vivo. J. Neurosci. 21 (2001) 3492-3502
6. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
7. Hashimoto K., Shimizu E., and Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Brain Res. Rev. 45 (2004) 104-114
8. Linden A.M., Vaisanen J., Lakso M., Nawa H., Wong G., and Castren E. Expression of Neurotrophins in rat brain after administration of antipsychotic and psychotropic agents. J. Mol. Neurosci. 14 (2000) 27-37
9. R. Machado-Vieira, M.O. Dietrich, R. Leke, V.H. Cereser, V. Zanatto, F. Kapczinski, D.O. Souza, L.V. Portela, V. Gentil. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode, Biol. Psychiatry, in press.
10. Minichiello L., and Klein R. TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons. Genes Dev. 10 (1996) 2849-2858
11. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA 95 (1998) 13290-13295
12. Pan W., Banks W.A., and Kastin A.J. Permeability of the blood-brain barrier to neurotrophins. Brain Res. 788 (1998) 87-94
13. Rajkowska G. Depression: what we can learn from postmortem studies. Neuroscientist 9 (2003) 273-284
14. Rajkowska G., Halaris A., and Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry 49 (2001) 741-752
15. Rosa A.R., Frey B.N., Andreazza A.C., Cereser K.M., Cunha A.B., Quevedo J., Santin A., Gottfried C., Gonçalves C.A., Vieta E., and Kapczinski F. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci. Lett. 47 (2006) 146-150
16. Schutte A., Yan Q., Mestres P., and Giehl K.M. The endogenous survival promotion of axotomized rat corticospinal neurons by brain-derived neurotrophic factor is mediated via paracrine, rather than autocrine mechanisms. Neurosci. Lett. 290 (2000) 185-188
17. Shirayama Y., Chen A.C., Nakagawa S., Russel D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22 (2002) 3251-3261
18. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., Schaffner S., Kirov G., Jones I., Owen M., Craddock N., DePaulo J.R., and Lander E.S. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol. Psychiatry 7 (2002) 579-593
19. Smith M.A., Makino S., Altemus M., Michelson D., Hong S.K., Kvetnansky R., and Post R.M. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc. Natl. Acad. Sci. USA 92 (1995) 8788-8792
20. Takebayashi M., Hisaoka K., Nishida A., Tsuchioka M., Miyoshi I., Koruzu T., Hikasa S., Okamoto Y., Shinno H., Morinobu S., and Yamawaki S. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int. J. Neuropsychopharmacol. 9 (2006) 607-612
21. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435